Home > Insider Trading > Filing (0001209191-19-038664)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1474553	William Ashton	11500 S. Eastern Ave., Suite 240 Henderson NV 89052		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value	Disposition	2019-06-19	5,000	$8.59	8,333	No	4	S	Direct
Common Stock, $0.001 Par Value	Disposition	2019-06-20	1,667	$8.50	6,666	No	4	S	Direct
Common Stock, $0.001 Par Value	Acquisiton	2019-06-20	10,000	$0.00	16,666	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2019-06-20	20,000	$0.00	20,000	$8.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2029-06-20	No	4	A	Direct

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2019.
100% of the restricted shares shall vest on the earlier of (1) June 20, 2020 or (2) the date of the company's 2020 Annual Meeting of Stockholders.
25% of the option shares vested on June 20, 2019. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.